Absorption |
Blood-Brain Barrier | BBB+ | 0.9678 |
Human Intestinal Absorption | HIA+ | 0.9817 |
Caco-2 Permeability | Caco2- | 0.5194 |
P-glycoprotein Substrate | Non-substrate | 0.7736 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9274 |
Non-inhibitor | 0.9567 |
Renal Organic Cation Transporter | Non-inhibitor | 0.9551 |
Distribution |
Subcellular localization | Mitochondria | 0.8149 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8049 |
CYP450 2D6 Substrate | Non-substrate | 0.9101 |
CYP450 3A4 Substrate | Non-substrate | 0.7798 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.9394 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9777 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9614 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9582 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9731 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9924 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9632 |
Non-inhibitor | 0.9825 |
AMES Toxicity | Non AMES toxic | 0.9424 |
Carcinogens | Carcinogens | 0.5436 |
Fish Toxicity | High FHMT | 0.5664 |
Tetrahymena Pyriformis Toxicity | Low TPT | 0.8768 |
Honey Bee Toxicity | High HBT | 0.6970 |
Biodegradation | Ready biodegradable | 0.9425 |
Acute Oral Toxicity | III | 0.8370 |
Carcinogenicity (Three-class) | Non-required | 0.7165 |